`Breakthrough'on arthritis
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A 68-year-old American woman has become the first recipient of gene therapy to treat rheumatoid arthritis, scientists said yesterday.
Initial results of the trial at the University of Pittsburgh Medical Center indicate that the insertion of a new, anti-arthritic gene into the patient was successful. It is not known whether the protein will continue to inhibit the disease in the long term, but it is being hailed as a breakthrough which paves the way for a new approach. The disease affects about 600,000 people in the UK. Liz Hunt
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments